Virology lecture #12: Infection basics
Download: .wmv (369 MB) | .mp4 (77 MB) Visit the virology W3310 home page for a complete list of course resources.
Download: .wmv (369 MB) | .mp4 (77 MB) Visit the virology W3310 home page for a complete list of course resources.
The World Health Organization and the US Food & Drug Administration have decided on the composition of the influenza virus vaccine that will be used during the 2010-2011 season in the northern hemisphere. The trivalent preparation will contain the following influenza virus strains: A/California/7/2009 (H1N1); A/Perth/16/2009 (H3N2); and B/Brisbane/60/2008. The same trivalent vaccine is also being used to …
Trivalent influenza vaccine for the 2010-2011 season Read More »
No matter what advanced method is used to develop and produce vaccines, their efficacy is limited by old technology – the refrigerator. All viral vaccines must either be stored frozen, or kept at low temperatures. If they are not properly stored, they lose potency and do not confer protection against infection. The decay of vaccine …
Download: .wmv (354 MB) | .mp4 (104 MB) Visit the virology W3310 home page for a complete list of course resources.
Download: .wmv (331 MB) | .mp4 (71 MB) Presented by guest lecturer Saul Silverstein, Ph.D. Visit the virology W3310 home page for a complete list of course resources.
The suggestion that the retrovirus XMRV is the etiologic agent of chronic fatigue syndrome (CFS) arose from a study in which the virus was found in 68 of 101 US patients. The virus was not detected in two independent studies of 186 and 170 CFS patients in the United Kingdom. A new Dutch study has also …
XMRV not detected in Dutch chronic fatigue patients Read More »